Al-Modawat Specialized Medical Company Statistics
Total Valuation
Al-Modawat Specialized Medical Company has a market cap or net worth of SAR 334.88 million. The enterprise value is 323.25 million.
Market Cap | 334.88M |
Enterprise Value | 323.25M |
Important Dates
The next estimated earnings date is Tuesday, December 3, 2024.
Earnings Date | Dec 3, 2024 |
Ex-Dividend Date | Nov 3, 2024 |
Share Statistics
Al-Modawat Specialized Medical Company has 23.75 million shares outstanding. The number of shares has increased by 8.72% in one year.
Current Share Class | n/a |
Shares Outstanding | 23.75M |
Shares Change (YoY) | +8.72% |
Shares Change (QoQ) | +17.45% |
Owned by Insiders (%) | 19.60% |
Owned by Institutions (%) | n/a |
Float | 4.75M |
Valuation Ratios
The trailing PE ratio is 26.85.
PE Ratio | 26.85 |
Forward PE | n/a |
PS Ratio | 3.91 |
PB Ratio | 4.27 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.59, with an EV/FCF ratio of -79.01.
EV / Earnings | 29.87 |
EV / Sales | 4.34 |
EV / EBITDA | 17.59 |
EV / EBIT | 22.85 |
EV / FCF | -79.01 |
Financial Position
The company has a current ratio of 2.74, with a Debt / Equity ratio of 0.17.
Current Ratio | 2.74 |
Quick Ratio | 2.34 |
Debt / Equity | 0.17 |
Debt / EBITDA | 0.71 |
Debt / FCF | -3.21 |
Interest Coverage | 12.51 |
Financial Efficiency
Return on equity (ROE) is 18.76% and return on invested capital (ROIC) is 12.75%.
Return on Equity (ROE) | 18.76% |
Return on Assets (ROA) | 9.27% |
Return on Capital (ROIC) | 12.75% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.78 |
Inventory Turnover | 8.50 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 14.49 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 43.78 |
Average Volume (20 Days) | 8,092 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Al-Modawat Specialized Medical Company had revenue of SAR 74.42 million and earned 10.82 million in profits. Earnings per share was 0.52.
Revenue | 74.42M |
Gross Profit | 36.30M |
Operating Income | 14.15M |
Pretax Income | 12.05M |
Net Income | 10.82M |
EBITDA | 16.06M |
EBIT | 14.15M |
Earnings Per Share (EPS) | 0.52 |
Balance Sheet
The company has 24.76 million in cash and 13.13 million in debt, giving a net cash position of 11.63 million or 0.49 per share.
Cash & Cash Equivalents | 24.76M |
Total Debt | 13.13M |
Net Cash | 11.63M |
Net Cash Per Share | 0.49 |
Equity (Book Value) | 78.51M |
Book Value Per Share | 3.31 |
Working Capital | 42.81M |
Cash Flow
In the last 12 months, operating cash flow was 2.31 million and capital expenditures -6.40 million, giving a free cash flow of -4.09 million.
Operating Cash Flow | 2.31M |
Capital Expenditures | -6.40M |
Free Cash Flow | -4.09M |
FCF Per Share | -0.17 |
Margins
Gross margin is 48.78%, with operating and profit margins of 19.01% and 14.54%.
Gross Margin | 48.78% |
Operating Margin | 19.01% |
Pretax Margin | 16.20% |
Profit Margin | 14.54% |
EBITDA Margin | 21.58% |
EBIT Margin | 19.01% |
FCF Margin | -5.50% |
Dividends & Yields
This stock pays an annual dividend of 0.28, which amounts to a dividend yield of 1.88%.
Dividend Per Share | 0.28 |
Dividend Yield | 1.88% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 213.31% |
Buyback Yield | -8.72% |
Shareholder Yield | -6.84% |
Earnings Yield | 3.72% |
FCF Yield | -1.22% |
Stock Splits
The last stock split was on June 10, 2024. It was a forward split with a ratio of 10.
Last Split Date | Jun 10, 2024 |
Split Type | Forward |
Split Ratio | 10 |
Scores
Al-Modawat Specialized Medical Company has an Altman Z-Score of 6.44.
Altman Z-Score | 6.44 |
Piotroski F-Score | n/a |